Biotech Startups

DST develops allergy and food intolerance diagnostic products for medical laboratories and healthcare professionals, including laboratory tests and point-of-care testing systems. The company focuses on tailored diagnostic solutions for different geographic regions.

1 investor

Durin Technologies (Durin Life Sciences) develops Duritect blood tests that combine autoantibody biomarkers with machine learning to assess a patient's risk of Alzheimer's disease and Parkinson's disease. The diagnostic tests run in a CLIA-certified, CAP-accredited laboratory and target early detection, subtyping, and staging of neurodegenerative diseases.

1 investor

DVLP is a biotechnology company developing vaccine platforms using artificial intelligence, synthetic biology, and immunology. The company appears to focus on next-generation vaccine development beyond mRNA technologies.

1 investor

Dx4Life develops a genetic swab test that identifies a biomarker to guide the choice of hormone treatment for patients undergoing IVF, delivering results in under an hour. The test is aimed at fertility clinics to help match each patient with the right hormone treatment before in vitro fertilization.

1 investor

DxLab develops multiplex molecular diagnostic technology (LAMP+) for rapid, low-cost point-of-care infectious disease testing, including its DxHub portable testing platform, DxTests, and ready-to-use LAMP master mixes. Founded by MIT and Harvard graduates, it serves public health applications such as Mpox and antimicrobial resistance detection.

1 investor

Dyegon develops sustainable textile inks and pigments produced from wild Patagonian bacteria as an eco-friendly way to color fabrics for the fashion industry. The company applies biotechnology and biomimicry to create natural dyes and is based in Chile.

1 investor

Dyneval builds benchtop hardware that measures motion at the micro- and nano-scale to analyze particles, microorganisms, and colloids. Its devices serve livestock fertility management as well as the pharmaceutical, biotechnology, and formulation industries with data for quality and production monitoring.

1 investor

1 investor

1 investor

E9 Genomics builds Urchin, an agentic biological search and reasoning platform that autonomously searches, integrates, and reasons over public and private biological data to help biopharma teams find non-obvious, high-value opportunities. It serves drug discovery teams for use cases such as indication selection, drug repurposing, and target prioritization, and currently operates as a collaborative service deploying Urchin on client projects.

1 investor

EADERM develops pharmaceuticals and therapeutics for hair loss and skin disorders based on tissue stem cell aging and regeneration control technology. The company targets treatment and prevention of alopecia and age-related skin conditions through innovative approaches centered on cellular mechanisms rather than symptomatic relief.

1 investor

Vow produces cultured (cell-based) meats grown from animal cells in bioreactors, creating novel meat products such as cultured Japanese quail rather than replicating conventional meat. It operates its own end-to-end food-grade manufacturing platform and sells its products through venues in several markets.

1 investor

The European Biochar Industry Consortium is a non-profit industry organization founded in 2019 to promote and support the European biochar sector through policy advocacy, market intelligence, communication, and industry standards development. It focuses on advancing biochar as a climate solution and circular economy material across Europe.

1 investor

EBVALLO is an on-demand allogeneic T-cell immunotherapy for treating relapsed or refractory EBV-positive post-transplant lymphoproliferative disease. The therapy uses anti-EBV-specific cytotoxic T-cells expanded from third-party donors and matched to patient HLA compatibility.

1 investor

Eccogene is a clinical-stage biopharmaceutical company developing oral small molecule therapeutics for cardiometabolic and inflammatory conditions, including obesity, type 2 diabetes, and liver disease. Its pipeline includes GLP-1 receptor agonist, THR-β, and SSAO programs, with its lead asset ECC5004 licensed to AstraZeneca.

1 investor

eClinical Solutions provides software and services that give clients access to clinical trial data. It serves organizations conducting clinical trials in the life sciences industry.

1 investor

Eclipse Regenesis develops a regenerative therapy platform for treating intestinal failure, starting with Short Bowel Syndrome, and extending to other complex gastrointestinal conditions. The company is a medical device developer focused on enabling the body's own tissue to rebuild rather than relying on invasive replacements.

1 investor

Eclo Beauty manufactures dietary supplements formulated to support skin health through carefully selected ingredients and optimized active forms. The company focuses on premium ingredient quality, bioavailability, and evidence-backed dosing for targeted nutritional support.

1 investor

A stealth-stage company developing targeted therapeutics.

1 investor

ECOAustralis develops biotechnology solutions for veterinary medicine that leverage native plants and sustainable practices while prioritizing ecosystem health and biodiversity. The company works with veterinarians to provide effective treatments that minimize environmental impact and promote sustainable animal and human health outcomes.

1 investor

Econic Biosciences is a biotech company developing cancer therapies that target extrachromosomal DNA (ecDNA), a driver of oncogene amplification and tumor evolution. It uses computational and analytical tools to identify and validate ecDNA-related therapeutic targets for treating cancer patients across diagnoses.

1 investor

Ecophage develops environmental solutions branded as proprietary products addressing sustainability challenges.

1 investor

Ecor1 Capital is an investment firm with a team of professionals across portfolio management, analysis, operations, and investor relations.

1 investor

Everest Clinical Research is a full-service contract research organization (CRO) that provides clinical trial delivery and biometrics services across more than 30 therapeutic areas. It serves pharmaceutical and biotech companies, offering clinical operations, data management, regulatory, and statistical support for studies worldwide.

1 investor